drugset / Trial / NCT00157924

Ezetimibe (+) Simvastatin vs. Atorvastatin Comparative Study in DM or Metabolic Syndrome Patients (0653A-093)

NCT00157924

Phase 4 Completed 190 enrolled Organon and Co
RandomizedParallel-groupOpen-labelTreatment

Summary

An efficacy and safety study of ezetimibe (+) simvastatin compared to atorvastatin at week 6 in diabetics or metabolic syndrome patients in Korea.

Timeline

Start
2005-11
Primary completion
2007-09
Completion
2007-09

Drugs

EvaluationDrugModalityDoseRoute
Comparator Atorvastatin Small molecule 10 mg
Subject Ezetimibe Unknown 20 mg
Subject Simvastatin Small molecule 10 mg

Indications